HK1142546A1 - Use of extracts from rabbit skin inflamed by vaccinia virus for the manufacture of a medicament for the treatment of acute cerebrovascular disease - Google Patents

Use of extracts from rabbit skin inflamed by vaccinia virus for the manufacture of a medicament for the treatment of acute cerebrovascular disease

Info

Publication number
HK1142546A1
HK1142546A1 HK10109154.1A HK10109154A HK1142546A1 HK 1142546 A1 HK1142546 A1 HK 1142546A1 HK 10109154 A HK10109154 A HK 10109154A HK 1142546 A1 HK1142546 A1 HK 1142546A1
Authority
HK
Hong Kong
Prior art keywords
medicament
extracts
manufacture
treatment
vaccinia virus
Prior art date
Application number
HK10109154.1A
Other languages
English (en)
Chinese (zh)
Inventor
劉萬生
Original Assignee
威世藥業 如皋 有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42169603&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1142546(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 威世藥業 如皋 有限公司 filed Critical 威世藥業 如皋 有限公司
Publication of HK1142546A1 publication Critical patent/HK1142546A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK10109154.1A 2008-11-11 2010-09-24 Use of extracts from rabbit skin inflamed by vaccinia virus for the manufacture of a medicament for the treatment of acute cerebrovascular disease HK1142546A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810176703.4A CN101732348B (zh) 2008-11-11 2008-11-11 牛痘疫苗致炎兔皮提取物在制备急性脑血管疾病治疗药物中的用途

Publications (1)

Publication Number Publication Date
HK1142546A1 true HK1142546A1 (en) 2010-12-10

Family

ID=42169603

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10109154.1A HK1142546A1 (en) 2008-11-11 2010-09-24 Use of extracts from rabbit skin inflamed by vaccinia virus for the manufacture of a medicament for the treatment of acute cerebrovascular disease

Country Status (20)

Country Link
US (1) US10265345B2 (xx)
EP (1) EP2364711B2 (xx)
JP (3) JP6085806B2 (xx)
KR (1) KR101756201B1 (xx)
CN (1) CN101732348B (xx)
AU (1) AU2009316168B2 (xx)
CA (1) CA2743090C (xx)
CY (1) CY1118457T1 (xx)
DK (1) DK2364711T3 (xx)
ES (1) ES2606051T5 (xx)
HK (1) HK1142546A1 (xx)
HR (1) HRP20161716T1 (xx)
HU (1) HUE030782T2 (xx)
LT (1) LT2364711T (xx)
NZ (1) NZ592696A (xx)
PL (1) PL2364711T3 (xx)
PT (1) PT2364711T (xx)
SI (1) SI2364711T1 (xx)
SM (1) SMT201600477B (xx)
WO (1) WO2010054531A1 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101732348B (zh) * 2008-11-11 2015-01-14 威世药业（如皋）有限公司 牛痘疫苗致炎兔皮提取物在制备急性脑血管疾病治疗药物中的用途
KR20220150424A (ko) * 2017-03-06 2022-11-10 준 리우 Aβ-유발 손상에 대한 신경 보호능을 측정하는 방법
CN109504649B (zh) * 2017-09-15 2022-06-14 天津小西生物医药科技有限公司 使用兔皮提取物促进细胞增殖的方法
KR20200103647A (ko) * 2017-12-28 2020-09-02 가꼬우호우징 효고 이카다이가쿠 리포칼린형 프로스타글란딘 d2 합성 효소 산생 촉진제
WO2020024142A1 (en) * 2018-08-01 2020-02-06 Vanford Bio-Drug Development Limited Novel peptides and its derivatives capable of stimulating cytokine release
WO2020211009A1 (zh) 2019-04-17 2020-10-22 诺希生物药物开发有限公司 痘苗病毒致炎兔皮提取物治疗造血系统损伤的用途
EP3984543A4 (en) 2019-06-14 2023-01-25 Mega Winning Limited USE OF AN EXTRACT FROM VACCINIA VIRUS INFLAMMATED RABBIT SKIN TO TREAT CANCER
CN110693914A (zh) * 2019-10-28 2020-01-17 威世药业（如皋）有限公司 痘苗病毒致炎兔皮提取物在治疗类风湿性关节中的应用
WO2023184471A1 (zh) * 2022-04-01 2023-10-05 星亮生物技术有限公司 痘苗病毒致炎兔皮提取物治疗帕金森病的用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4985254A (en) 1987-11-06 1991-01-15 Nippon Zoki Pharmaceutical Co., Ltd. Method of treating ischemic diseases
JP2539665B2 (ja) * 1988-06-20 1996-10-02 日本臓器製薬株式会社 神経疾患治療剤
JP2732379B2 (ja) * 1995-12-18 1998-03-30 日本臓器製薬株式会社 知覚異常改善剤
US6197806B1 (en) 1995-12-20 2001-03-06 Nippon Zoki Pharmaceutical Co., Ltd. Eliminating agent for activated oxygen and free radicals
ES2285740T3 (es) * 1996-09-27 2007-11-16 The Trustees Of Columbia University In The City Of New York Tratamiento de un trastorno isquemico y mejora de las consecuencias de un accidente cerebrovascular.
JP4033936B2 (ja) * 1997-01-08 2008-01-16 日本臓器製薬株式会社 一酸化窒素産生抑制剤
JP2000016942A (ja) 1998-04-27 2000-01-18 Nippon Zoki Pharmaceut Co Ltd 虚血性疾患治療剤
KR19990083516A (ko) 1998-04-27 1999-11-25 고니시 진우에몬 허혈성질환치료제
CN1055249C (zh) * 1998-07-15 2000-08-09 沈继平 一种镇痛药和其制造方法
JP2000143536A (ja) 1998-11-13 2000-05-23 Nippon Zoki Pharmaceut Co Ltd 抗浮腫剤
JP2001058949A (ja) 1999-08-20 2001-03-06 Fujimoto Brothers:Kk 抗ショック剤
JP4612924B2 (ja) 1999-08-20 2011-01-12 藤本製薬株式会社 サイトカイン調節剤
CN1207005C (zh) 2002-10-31 2005-06-22 威世药业（如皋）有限公司 含生物活性物质的兔皮和其用途
JP3818657B2 (ja) 2004-12-01 2006-09-06 日本臓器製薬株式会社 乾燥物及びその製造方法
KR101307999B1 (ko) 2004-12-01 2013-09-12 니폰 조키 세야쿠 가부시키가이샤 건조물 및 그 제조방법
ES2524015T3 (es) * 2005-12-30 2014-12-03 Dyax Corporation Proteínas de enlazamiento a la metaloproteinasa
TWI406664B (zh) 2006-03-30 2013-09-01 Univ Kyoto 硫氧還蛋白（ｔｈｉｏｒｅｄｏｘｉｎ）產生促進劑
CN101732348B (zh) * 2008-11-11 2015-01-14 威世药业（如皋）有限公司 牛痘疫苗致炎兔皮提取物在制备急性脑血管疾病治疗药物中的用途

Also Published As

Publication number Publication date
CN101732348B (zh) 2015-01-14
CA2743090C (en) 2021-04-27
CY1118457T1 (el) 2017-07-12
WO2010054531A1 (zh) 2010-05-20
AU2009316168A1 (en) 2010-05-20
US10265345B2 (en) 2019-04-23
CN101732348A (zh) 2010-06-16
KR20110086136A (ko) 2011-07-27
HUE030782T2 (en) 2017-06-28
US20110268814A1 (en) 2011-11-03
EP2364711B1 (en) 2016-10-12
JP2017052788A (ja) 2017-03-16
KR101756201B1 (ko) 2017-07-10
EP2364711A1 (en) 2011-09-14
EP2364711B2 (en) 2019-10-30
HRP20161716T1 (hr) 2017-02-10
ES2606051T5 (es) 2020-05-14
PT2364711T (pt) 2017-01-18
JP2012508192A (ja) 2012-04-05
DK2364711T3 (en) 2017-01-30
AU2009316168B2 (en) 2015-03-12
ES2606051T3 (es) 2017-03-17
JP6085806B2 (ja) 2017-03-01
LT2364711T (lt) 2017-03-10
SMT201600477B (it) 2017-03-08
PL2364711T3 (pl) 2017-07-31
JP2015028076A (ja) 2015-02-12
EP2364711A4 (en) 2012-12-12
NZ592696A (en) 2013-02-22
CA2743090A1 (en) 2010-05-20
SI2364711T1 (sl) 2017-05-31

Similar Documents

Publication Publication Date Title
HK1142546A1 (en) Use of extracts from rabbit skin inflamed by vaccinia virus for the manufacture of a medicament for the treatment of acute cerebrovascular disease
BRPI0917567A2 (pt) tratamento de doença respiratória
BRPI0906467A2 (pt) forma de dose farmacêutica
IL217901B (en) Use of laquinimod or a laquinimod salt in the manufacture of a drug for the treatment of bdnf-related diseases
BRPI0819630A2 (pt) Montagem de interface de paciente para terapia respiratória
DK2488242T3 (da) Medicinsk indåndingsmaske
ZA201403549B (en) Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation
DK2627345T3 (da) Formuleringer til behandling af sygdomme i de øvre luftveje
GB0906159D0 (en) Drug combination for the treatment of proteostatic diseases
GB201002243D0 (en) Respiratory disease treatment
DE102009018133A8 (de) Pharmazeutische Zusammensetzung zur Behandlung von dermatologischen Autoimmunerkrankungen
DK2379066T3 (da) Anvendelse af opioidantagonister til fremstilling af et lægemiddel til behandling af retinadegenerationssygdomme
GB201002224D0 (en) Respiratory disease treatment
IL213606A0 (en) 1-amino-alkylcyclohexane derivatives for the treatment of inflamatory skin diseases
IL216717A (en) Use of benzidamine in the manufacture of a drug for the treatment of p40-dependent diseases
DK2344166T3 (da) Farmaceutisk præparat til behandlingen af gastrointestinale irritationslidelser
IT1402712B1 (it) Unita' per l'esecuzione di trattamenti estetici, cosmetici e terapeutici.
ES1067182Y (es) "maletin de asistencia medica"
TH0801000702A (th) อะคลิดิเนียมสำหรับใช้โดยการสูดในการบำบัดโรคทางเดินหายใจ
TH0901000513A (th) อนุพันธ์สไปโรไซคลิค แอมีดสำหรับการรักษาโรคปอด
GB0801511D0 (en) The treatment of ophthalmic diseases
GB0823568D0 (en) Respiratory disease treatment
ES1071962Y (es) Parche fisico potenciador de la respiracion nasal
BR112013023187A2 (pt) regimes de dosagem para o tratamento da doença de fabry
GB201018325D0 (en) Treatment for dupuytren's disease